TLPH — TALPHERA, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1427925 ·
Last close
$1.18
Market Cap
$61.25M
52W High
$1.57
52W Low
$0.69
ADV30
166,020
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -3,924,000 | -4,312,000 | 26,806,000 | 742,000 | 12,400,000 |
| Mar 2026 | 0 | — | -3,948,000 | -2,556,000 | 30,155,000 | 3,823,000 | 11,677,000 |
| Dec 2025 | 0 | — | -3,453,000 | -3,772,000 | 29,719,000 | 5,894,000 | 12,684,000 |
| Sep 2025 | 1,000 | — | -3,422,000 | -4,436,000 | 30,742,000 | 3,457,000 | 11,565,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,294,000
Investing CF
$-17,059,000
Financing CF
$26,788,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.31
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-474,076,000
Inventory
—
Receivables
—
ST Investments
$17,285,000
EBIT TTM
$-15,645,000
Pretax Income TTM
$-14,253,000
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,000
EBITDA
—
Free Cash Flow
$-6,870,875
Enterprise Value
$53,786,188
Total Cash
$17,076,000
Total Debt
$6,499,000
Shares Out
51,905,796
Trailing EPS
$-0.23
Book Value
$0.37
ROE
-143.4%
ROA
-42.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,000 | -13,484,000 | -14,290,000 | 29,719,000 | 12,684,000 | 17,035,000 | -11,364,000 |
| Dec 2024 | 0 | -15,252,000 | -13,004,000 | 18,236,000 | 10,235,000 | 8,001,000 | -12,683,000 |
| Dec 2023 | 651,000 | -16,889,000 | -18,397,000 | 20,395,000 | 6,290,000 | 14,105,000 | -17,492,000 |
| Dec 2022 | 0 | -20,352,000 | 47,755,000 | 47,487,000 | 25,673,000 | 21,814,000 | -28,331,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.24
Max Pain — expiry 2026-12-18
max pain strike: $1.00 · spot: $1.18 · call oi: 3,377 · put oi: 1,882
Expected Move to 2026-12-18:
±$0.55
(46.41%) —
implied range
$0.63 –
$1.73
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZYBT | Zhengye Biotechnology Holding Ltd | $61.85M | $1.30 | — |
| BOLD | Boundless Bio, Inc. | $60.51M | $2.66 | — |
| HYPD | HYPERION DEFI, INC. | $62.78M | $4.04 | — |
| XLO | Xilio Therapeutics, Inc. | $59.48M | $9.04 | — |
| MREO | Mereo BioPharma Group plc | $59.09M | $0.37 | — |
News headlines (Yahoo Finance, 1h cache)
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-03 12:30 · Yahoo
Talphera (TLPH) Q2 2026 Earnings Call Transcript
2026-08-19 21:28 · Yahoo
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO Study Enrollment Hits 75% as ...
2026-08-13 05:03 · Yahoo
Talphera Q2 Earnings Call Highlights
2026-08-13 03:04 · Yahoo
Talphera Inc (TLPH) Q1 2026 Earnings Call Highlights: Strong NEFRO Study Progress Amid Rising ...
2026-05-14 05:02 · Yahoo
Talphera Q1 2026 Earnings Call Transcript
2026-05-13 21:40 · Yahoo
Talphera (TLPH) Q1 2026 Earnings Transcript
2026-05-13 21:37 · Yahoo
Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-13 20:05 · Yahoo
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
2026-05-07 20:05 · Yahoo
Talphera (TLPH) Upgraded to Buy: Here's What You Should Know
2026-09-21 16:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.